COMMUNIQUÉS West-GlobeNewswire

BiomX: Next-Gen Counter Drone Solutions will be Showcased by DFSL at ISC 2026
24/06/2026
NETANYA, Israel, June 24, 2026 (GLOBE NEWSWIRE) -- BiomX Inc. (NYSE American: PHGE) (“BiomX” or the “Company”) today announced that its majority-owned subsidiary company DFSL Ltd. (“DFSL”) will showcase next-generation [...]
Wave Life Sciences Announces Initiation of Phase 2a Portion of INLIGHT™ Trial of WVE-007 (INHBE GalNAc-siRNA) for Obesity and Cardiometabolic Diseases
24/06/2026
In Phase 1 portion of trial, WVE-007 improved body composition by inducing fat loss, including harmful visceral fat, while maintaining muscle; data continue to support once or twice-yearly dosing Phase 2a portion in [...]
Onconetix Highlights Realbotix’s Launch of Humanoid Robot and AI Teachers Assistant Pilot Program in New York State School District
24/06/2026
Salamanca City Central School District on Seneca Nation Reservation to Deploy Optio and Realbotix M-Series Humanoid Robot; Pilot to Expand to Approximately 500 High School Students in Fall 2026; Onconetix Recently [...]
The Quest to Repair What Multiple Sclerosis Takes Away
24/06/2026
AUSTIN, Texas, June 24, 2026 (GLOBE NEWSWIRE) -- BioMedWire Editorial Coverage : Multiple sclerosis (“MS”) gradually strips people of command over their own bodies, advancing steadily with no available cure. More than 2 [...]
LENZ Therapeutics and Arrotex Pharmaceuticals Announce Exclusive License and Commercialization Agreement for VIZZ™ in Australia and New Zealand
24/06/2026
Exclusive license and commercialization agreement includes a significant profit share of gross margin from product sales in addition to an upfront license payment to LENZ SAN DIEGO and MELBOURNE, Australia, June 24, [...]
Next-Generation DNA Repair Inhibitors Could Capture Billions in Emerging Market
24/06/2026
AUSTIN, Texas, June 24, 2026 (GLOBE NEWSWIRE) -- BioMedWire Editorial Coverage : Oncology research is moving through one of its most active stretches in years. DNA Damage Response (“DDR”) inhibitors, a category of drugs [...]
Bionano Announces Hiring of Chief Scientific Officer
24/06/2026
SAN DIEGO, June 24, 2026 (GLOBE NEWSWIRE) -- Bionano Genomics, Inc. (NASDAQ: BNGO), a leader in genome analysis solutions, today announced the appointment of Alex Hastie, Ph.D. , as its Chief Scientific Officer (CSO) , [...]
AIM ImmunoTech Accelerates Toward Potential Pivotal Pancreatic Cancer Program as Ampligen Continues to Advance Through Key Clinical Milestones
24/06/2026
Recent Clinical Progress, Enrollment Achievements, Expanded Intellectual Property Portfolio and Strengthened Financial Position Support a Potentially Transformative 12-Month Value Creation Opportunity OCALA, Fla., June [...]
BrewDog and Tilray Beer Are Ready to Pour the World’s Biggest Bar Tab — £1 Million of Free Pints
24/06/2026
Jersey on. Crew ready. If England, Scotland or the U.S. reaches the final, fans can head straight to participating BrewDog pubs 1 and Tilray-owned brewpubs 2 across the U.S. to claim up to two free pints before the £1 [...]
Noom Members Regained 3x Less Weight After Stopping GLP-1s vs Standard-of-Care, New Analyses Show
24/06/2026
In two analyses, Noom members were modeled to gain less than 2% of bodyweight up to 12 months after stopping medication — with the strongest maintenance among those who continued practicing healthy habits Noom members [...]
Profusa Shareholders Approve Strategic Initiatives at 2026 Annual Meeting, Supporting PanOmics Acquisition, Balance Sheet Strengthening and Nasdaq Compliance Efforts
24/06/2026
BERKELEY, Calif., June 24, 2026 (GLOBE NEWSWIRE) -- Profusa, Inc. (Nasdaq: PFSA), a digital health company pioneering next-generation biosensing technologies, announces that shareholders approved all proposals presented [...]
Enlivex Treasury Portfolio Update: Listing of the RAIN Token on Gate, One of the World's Largest Cryptocurrency Exchanges by Spot Trading Volume
24/06/2026
Ranked second globally in 24-hour spot trading volume, Gate further extends market access and secondary liquidity for Enlivex ’ s primary digital treasury asset Nes-Ziona, Israel, June 24, 2026 (GLOBE NEWSWIRE) -- [...]
VERAXA Biotech Expands R&D Hub in Heidelberg as Innovative BiTAC™-TCE and ADC Programs Advance Towards Clinical Development
24/06/2026
Greater than 60% increase in laboratory space will strengthen R&D capabilities, facilitate acceleration toward clinical development, and increase ability to tap into Heidelberg’s world-class medical oncology [...]
RAMSAY SANTE lance le refinancement de sa dette senior
24/06/2026
COMMUNIQUÉ DE PRESSE Paris, le 24 juin 2026 Ramsay Santé lance le refinancement de sa dette senior Ramsay Santé annonce aujourd’hui le lancement du refinancement de sa dette senior pour un montant total de 1,75 [...]
OrthoPediatrics Announces Distribution Agreement with OSSIO, Inc. to Provide Revolutionary Orthopedic Fixation Technology to U.S. Children’s Hospitals Nationwide
24/06/2026
WARSAW, Ind., June 24, 2026 (GLOBE NEWSWIRE) -- OrthoPediatrics Corp. (“OrthoPediatrics” or the “Company”) (Nasdaq: KIDS), a company focused exclusively on advancing the field of pediatric orthopedics, today announced [...]
Mammogen Appoints Physician Executive and Breast Imaging Leader, Dr. Elise Berman, as Chief Medical Officer
24/06/2026
Berman Joins Mammogen to Support Next Phase of Growth Following $30 Million Series A Financing to Advance RNA-Based Breast Cancer Detection Platform NEWPORT BEACH, Calif., June 24, 2026 (GLOBE NEWSWIRE) -- Mammogen , a [...]
TScan Therapeutics to Participate in the H.C. Wainwright 4th Annual Cell Therapy Virtual Conference
24/06/2026
WALTHAM, Mass., June 24, 2026 (GLOBE NEWSWIRE) -- TScan Therapeutics, Inc. (Nasdaq: TCRX), a clinical-stage biotechnology company focused on the development of T cell receptor (TCR)-engineered T cell (TCR-T) therapies [...]
PetVivo Holdings Announces Transformative Acquisition Of PiezoBioMembrane To Build a Leading Functional Biomaterials Platform
24/06/2026
Acquisition Strengthens Company's Intellectual Property Portfolio and Creates New Opportunities for Medical Device and Therapeutic Product Development Across Animal and Human Health Markets MINNEAPOLIS, MN, US, June 24 [...]
Calidi Biotherapeutics Presents New Data on CLD-501, Its In Situ T-Cell Engager Candidate Targeting TROP-2 at the T-Cell Engager Therapeutic Summit
24/06/2026
Findings highlight RedTail’s potential to overcome historical limitations of T-cell engagers in solid tumors through tumor-specific, localized expression SAN DIEGO, June 24, 2026 (GLOBE NEWSWIRE) -- Calidi [...]

Pages